Content reflects the views of the posting party and is provided for informational purposes only. It does not constitute a solicitation, recommendation, endorsement, or investment advice by BioTech Funding Portal. All content is subject to the portal’s Community Content Guidelines.
Brian Christie
Co-Founder
BioTech Social Inc.
Entrepreneur and inventor operating at the intersection of technology, finance, and regulation. View (0) Answers
Karin Hellsvik
Vice President, Head of IR & Comms; Strategic Advisor
Foghorn Therapeutics
Executive with 20+ years of experience and passion for improving patient care; building long-term value for biotech investors View (0) Answers
Chris Hopkins
CEO
Glafabra Therapeutics
Developing durable cell-based gene therapies for Fabry, Gaucher, Pompe & other enzyme deficiencies. View (0) Answers
Robert Barich
Managing Director
CNR Search
25+ years in executive search, life sciences investing, and company-building to match leaders with business needs. View (0) Answers
Tetsu Yung
Director of JAPAC Strategy
Glafabra Therapeutics
Building JAPAC strategy for Glafabra to advance durable, cell-based therapy for Fabry disease patients View (0) Answers
Brian Freeman
CEO & Co-Founder
Energesis Pharmaceuticals
Entrepreneur & physician with deep experience in obesity and a drive to help provide better solutions for patients View (0) Answers
Eydith Comenencia Ortiz
Founder
CONECTA
Executive with 15 years of experience advancing biotech innovation with evidence-based patient engagement & insights generation View (0) Answers
